Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Homcy Insider Profile
4 Followers
Charles Homcy, Former Director at Portola Pharma, holds 297.87K shares in Portola Pharma (Ticker: PTLA), holds ― shares in MyoKardia (Ticker: MYOK), holds 1.23M shares in BridgeBio Pharma (Ticker: BBIO). Most recently, Charles Homcy Bought ― shares of Portola Pharma on Jan 04, 2019 for an estimated value of 234.21K.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+12.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Charles Homcy holds in companies
Most Profitable Insider Trade
Stock:
Portola Pharma
(PTLA)
(PTLA)
Rating:Informative Buy
Date:Dec 19, 2018 - Dec 19, 2019
Return:+51.50%
The most profitable trade made by Charles Homcy
Charles Homcy's Trading History
Portola Pharma
Jan 04, 2019
―
Informative Buy
234.21K
$5.37M
MyoKardia
―
―
―
―
Global Blood Therapeutics
Oct 27, 2017
―
Informative Sell
2.38M
$4.75M
BridgeBio Pharma
Feb 21, 2024
Director
Uninformative Buy
―
$34.23M
Pliant Therapeutics
―
Director
―
―
Geron
May 13, 2011
Director
Uninformative Buy
―
$246.61K
Cytokinetics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Charles Homcy's performance on stock
You May Also Like
Charles Homcy insider profile FAQ
What is the percentage of profitable transactions made by Charles Homcy?
The percentage of profitable transactions made by Charles Homcy is 60%.
What is the average return per transaction made by Charles Homcy?
The average return per transaction made by Charles Homcy is 12.60%.
What stocks does Charles Homcy hold?
Charles Homcy holds: PTLA, MYOK, GBT, BBIO, PLRX, GERN, CYTK stocks.
What was Charles Homcy’s latest transaction?
Charles Homcy latest transaction was an Informative Buy of $234.21K.
What was Charles Homcy's most profitable transaction?
Charles Homcy’s most profitable transaction was an Informative Buy of PTLA stock on December 19, 2018. The return on the trade was 51.50%.
What is Charles Homcy's role in Portola Pharma?
Charles Homcy's role in Portola Pharma is Former Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.